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Mtv-2 is an endogenous mouse mammary tumor virus (MMTV) that is responsible for the induction of mammary gland
tumors in the high mammary gland tumor-incidence strain GR. GR animals inherit four different endogenous MMTVs in
addition to Mtv-2: Mtv-3, Mtv-7, Mtv-8 and Mtv-17. In this study we analyzed the involvement of these nonpathogenic
endogenous proviruses in the mammary gland tumors caused by Mtv-2. We showed that Mtv-17 is expressed in the
mammary gland of GR mice, efficiently packaged into virions, and shed into milk. DNA isolated from both mammary gland
tumors and the nonmalignant mammary gland tissues of GR mice contained amplified copies of both newly acquired Mtv-
2 and recombinant proviruses with the env gene derived from Mtv-17. A small percentage of these tumors contained
predominantly recombinant viruses. These findings suggest a role for Mtv-17 in the mammary gland tumors induced by
Mtv-2 in GR mice. q 1996 Academic Press, Inc.
crease their tumor incidence (Michalides and Schlom,INTRODUCTION
1975).
GR mice are characterized by the presence of viralMouse mammary tumor virus (MMTV) is transmitted
particles in milk and the development of early pregnancy-from one generation to the next by two mechanisms:
dependent mammary tumors in 97% of animals (Muhl-horizontally through milk (exogenous or milk-borne virus)
bock, 1965). These tumors are not due to an exogenousand vertically through the germ line (endogenous virus)
MMTV, since GR offspring foster-nursed on MMTV-free(Bentvelzen, 1972). Although all commonly used strains
females develop mammary tumors as frequently as thoseof mice contain several endogenous MMTV proviruses,
nursed on GR females (Bentvelzen and Daams, 1969). Inonly certain strains transmit an exogenous virus (Varmus
this strain, a single dominant gene, Mtv-2, controls bothet al., 1972, Michalides and Schlom, 1975). For instance,
the early appearance of mammary tumors and the pres-exogenous MMTV is transmitted through the milk of GR
ence of MMTV virions in milk (Muhlbock and Bentvelzen,and C3H but not BALB/c and C57BL mice (Moore et al.,
1968; van Nie et al., 1977). DNA isolated from tumors1979).
that develop in GR mice always contains more proviralThe presence of exogenous MMTV in a mouse strain
copies of Mtv-2 than DNA isolated from their nonmalig-usually correlates with a high incidence of mammary
nant tissues (Cohen and Varmus, 1980). It is thought thatgland tumors. Conversely, mice that produce no MMTV
reinfection of the mammary gland cells by the Mtv-2-in their milk have a low incidence of mammary gland
encoded virus results in these new integrations. Removaltumor formation (Bentvelzen, 1968). Tumor DNA from ani-
of this locus by cross-breeding has resulted in a lowmals infected with exogenous MMTV always contains
incidence mammary tumor congenic strain, GR.Mtv-20additional MMTV proviruses that are the result of infec-
(van Nie and de Moes, 1977).tion by this milk-borne virus (Cohen et al., 1979; Morris
We recently showed that viral RNA transcribed fromet al., 1977). MMTV lacks an oncogene and appears to
the Mtv-1 locus in the lactating mammary glands of C3H/induce tumors by acting as an insertional mutagen that
HeN MMTV/ mice could be copackaged with exogenousactivates expression of cellular oncogenes (Peters and
MMTV(C3H) virus (Golovkina et al., 1994, 1995). An un-Dickson, 1987). By foster-nursing the pups of high mam-
known mutation in the Mtv-1 genome prevents it frommary tumor-incidence strains, such as C3H/He MMTV/,
being packaged in the absence of the proteins suppliedon females from low-incidence strains, it is possible to
by the exogenous virus. Approximately 30% of mammaryfree them of exogenous MMTV and dramatically de-
gland tumors that appeared in C3H/HeN MMTV/ mice
contained newly acquired copies of only recombinant
viruses, with their env gene derived from Mtv-1 (Golov-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (215)573-2028. E-mail: Rosss@mail.med.upenn.edu. kina et al., 1994). We hypothesized that recombination
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between different endogenous and exogenous MMTV lovkina et al., 1994). One microgram of viral RNA was
used for RNase T1 protection assays.could be important in virus-induced tumorigenesis.
To analyze whether recombination between an endog-
Southern blot analysisenous, nonpathogenic MMTVs and Mtv-2 occurs in GR
animals, we examined the newly integrated proviruses
Mammary gland tumors as well as normal mammary
in the normal mammary glands and mammary gland tu-
gland tissue were excised from the surrounding tissues,
mors of virgin GR females. We show here that the Mtv-
and DNA was isolated by proteinase K–sodium dodecyl
17 locus is expressed in the lactating mammary glands
sulfate digestion followed by phenol-chloroform extrac-
and packaged into milk-borne virions in GR mice, but not
tion and ethanol precipitation. Fifteen micrograms of
in a strain of mice (B10.BR) that contains Mtv-17 and no
each DNA were digested with the indicated restriction
Mtv-2. In addition, we show that many Mtv-2-induced
enzymes as instructed by the manufacturer (New En-
mammary gland tumors in GR mice contain recombinant
gland Biolabs, Inc., MA) and electrophoresed on 0.8%
viruses that have their env gene derived from Mtv-17.
agarose gels. After transfer to nylon membrane, the blots
The recombinant proviruses also could be detected in
were hybridized with the 32P-labeled probe diagrammed
the nonmalignant mammary gland tissues of tumor-bear-
in Fig. 4, washed, and exposed to Kodak XAR5 film, using
ing mice. These results suggest that Mtv-2 efficiently
Cronex Lightening Plus intensifying screens.
superinfects epithelial cells of the mammary gland in the
Quantitation was performed using a PhosphorImager
presence of Mtv-17.
(Molecular Dynamics, Inc., Sunnyvale, CA). Hybridization
of the blots to a unique gene, FAS-L, showed that thereMATERIALS AND METHODS
was no amplification of the hybridization signal to the
Mice 3.0-kb gag-pol fragment (data not shown) (generated
upon BglII/PstI digestion of all endogenous MMTVs ex-Female C3H/HeN MMTV0 or MMTV/ and AKR/NCr
cept Mtv-2; see Fig. 4) in the mammary gland or mam-mice from colonies of germ-free-derived, defined-flora
mary gland tumor DNA relative to spleen DNA. Therefore,animals were purchased from the National Institute of
we normalized radioactivity in all bands to the gag-polHealth Frederick Cancer Research Facility (Frederick,
fragment in each DNA sample. The additional proviralMD). Female B10.BR mice from colonies of germ-free-
copy number in the mammary gland tumors and normalderived, defined-flora animals were purchased from the
tissue DNA presented in Table 1 were calculated asJackson Laboratory (Bar Harbor, ME). Female GR mice
follows: for all MMTVs except Mtv-2, b/[(a 1 1.7)/8] - 8were obtained from the breeding colony maintained at
and for Mtv-2, c/[(a 1 1.7)/8] - 2, where a representsthe Alton Ochsner Medical Foundation (New Orleans)
radioactivity hybridized to the 3.0-kb gag-pol fragment, bsince 1986.
represents radioactivity hybridized to the 2.1-kb pol-env
RNase T1 protection assay fragment, c represents radioactivity hybridized to the 2.3-
kb pol-env fragment, and 1.7 is the ratio of radioactivityA region containing 3* LTR sequences present in all
hybridized to the 2.1-kb pol-env fragment relative to thethree viral transcripts (filled box in Fig. 1) was isolated
3.0-kb gag-pol fragment in DNA isolated from GR spleen.as Sau 3A– Sau 3A fragment of 220 base pair (bp) from
Eight is the total number of endogenous MMTV provi-a plasmid carrying the Mtv-7 LTR (Beutner et al., 1992)
ruses excluding Mtv-2; two is the number of Mtv-2 provi-[map positions nucleotide (nt) 743 to 963 (Brandt-Carlson
ruses in the GR genome.et al., 1993)] or 340 bp from plasmid TR1.10, carrying the
3* EcoRI fragment of Mtv-9 (Peterson et al., 1985) [map
Reverse transcription (RT)-PCR analysisposition nt 743 to 1083]. These fragments were cloned
into the BamHI site of the pBluescript vector (Stratagene, Total RNA (10 mg) isolated from lactating mammary
Inc., CA) (narrow open boxes in Fig. 1). The probes spe- glands was reverse-transcribed with SuperScript II re-
cific for the Mtv-1/3 and MMTV(C3H) sag regions were verse transcriptase in the buffer supplied by the manufac-
described elsewhere (Golovkina et al., 1994). For the gen- ture (GIBCO/BRL) and a (dT)15 primer (Promega). One-
eration of probes, the plasmids were cut with XhoI and T3 third of each cDNA preparation was used for polymerase
RNA polymerase was used to create a [32P]UTP-labeled chain reaction (PCR) with reverse primers specific for
antisense RNA. Twenty micrograms of total RNA isolated the Mtv-2 sag (5* TAA TGT TCT ATT AGT CCA GCC ACT
from the mammary glands and lymphoid organs of differ- GT 3*, positions nt 923-898) or the Mtv-17 sag (5* CCT
ent strains of mice were used for RNase T1 protection TAT GTC AAA GGT ATC CAC AG 3*, nt 951-929); the
analysis as previously described (Golovkina et al., 1994). forward primer was specific for the env gene coding
region of all endogenous and exogenous MMTVs (5*
Isolation of viral RNA from the milk GAT GAA GAA ACA CCA ATC TGG GTC 3*) (Majors and
Varmus, 1983) (Fig. 4). MMTV-specific transcripts wereViral RNA was isolated from the milk of GR, B10.BR,
and C3H/HeN MMTV/ mice as previously described (Go- amplified by 35 cycles of PCR (957 for 1 min, 557 for 1
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min, 727 for 3 min) using TaqPlus DNA polymerase with with distinct Vb chains and this specificity is determined
by the C-terminal hypervariable domain (Brandt-CarlsonTaq Extender PCR Additive (Stratagene). The PCR prod-
ucts were cut with PvuII, MunI, or PvuII and MunI (New et al., 1993; Choi et al., 1992). We used probes spanning
the hypervariable region of four different MMTVs forEnglang Biolab) and separated on 1% agarose gels.
RNase T1 protection analysis, Mtv-1, -7, -9 and MMTV-
(C3H). The Mtv-1-specific probe hybridizes to RNA tran-RESULTS
scribed from Mtv-1, -3, and -6 (herein called the
Tissue-specific expression of different endogenous Mtv-1/3-specific probe) (Golovkina et al., 1994; Brandt-
MMTVs present in the GR genome Carlson et al., 1993). The MMTV(C3H)-specific probe is
protected by RNA transcribed from the Mtv-2 and -11 lociRecombination between different retroviruses requires
and MMTV(C3H) exogenous virus (herein called the Mtv-copackaging of two distinct viral RNA molecules in the
2-specific probe) (Golovkina et al., 1994). In addition, twosame virion followed by reinfection of cells with such
other probes, one specific for Mtv-7 and the other forheterozygous viral particles (Coffin, 1990). Defective en-
Mtv-9 and -17 (Mtv-9/17-specific probe), were generateddogenous MMTV proviruses that are highly expressed
(Fig. 1). Thus, using these four probes we were able toin cells infected by exogenous viruses can be copack-
distinguish the different RNA molecules produced fromaged and are thus potential participants in retroviral re-
the four transcribed MMTV loci (Mtv-2, -3, -7, and -17)combination. GR mice inherit four MMTV proviruses, Mtv-
present in the GR genome; it previously has been shown3, -7, -8, and -17, in addition to the infectious Mtv-2 provi-
that the Mtv-8 locus is silent in many tissue culture cellrus (Kozak et al., 1987). To determine which of these
lines (Yang and Dudley, 1992).proviruses was a potential participant for recombination
RNase T1 protection analysis was performed with totalwith Mtv-2 in the mammary gland, we first analyzed the
RNA isolated from the lactating and virgin mammarytissue-specific expression pattern of these loci.
glands and spleen of GR mice (Fig. 2). In addition weThe superantigen (Sag) protein encoded in the long
analyzed RNA from the lactating mammary glands ofterminal repeat (LTR) of MMTV interacts with the Vb
B10.BR (Mtv-8, -9, and -17), C3H/HeN MMTV/ (Mtv-1,chain of the T-cell receptor (Acha-Orbea et al., 1991; Choi
et al., 1991). Different MMTVs encode Sags that interact -6, -8, -11, -14 and MMTV(C3H)), C3H/HeN MMTV0 (Mtv-
FIG. 1. Diagram of the MMTV provirus, the three viral transcripts, and the probes used for RNase T1 protection assays. The Sau 3A–Sau 3A
fragment subcloned from plasmids containing the LTRs of different MMTVs as described under Materials and Methods is shown as a solid box,
while the open boxes represent plasmid sequences. There are two Sau 3A sites in the LTRs of MMTV(C3H), Mtv-1 and -9 [positions nt 743 and
1083 according to Brandt-Carlson et al. (1993)]; therefore, the sizes of the probes were 440 nt (MMTV(C3H) and Mtv-9/17) or 443 nt (Mtv-1/3) and
the sizes of protected fragments were 340 nt (MMTV(C3H) and Mtv-9/17) or 343 nt (Mtv-1/3). The LTR of Mtv-7 has an additional Sau 3A at the
position 963 (marked sS on Fig. 1); therefore, the sizes of the produced probe and protected fragment were 320 nt and 220-nt, respectively. Due
to the sequence dissimilarities between the LTRs of MMTV(C3H) (source of the probe) and Mtv-2 in the region between 787 and 797 nt, Mtv-2 RNA
protects a 280-nt fragment. S, Sau 3A.
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FIG. 2. Expression of endogenous MMTVs in the mammary gland and lymphoid tissues of GR mice. RNA, isolated from GR virgin mammary
gland (lanes 4, 9, and 17), lactating mammary gland (lanes 5, 10, 11, and 18), and spleen (lanes 3, 8, 12, and 16); B10.BR lactating mammary gland
(lanes 7); C3H/HeN MMTV/ lactating mammary gland (lane 2); C3H/HeN MMTV0 lactating mammary gland (lane 15) and AKR/NCr spleen (lane
13) were subjected to RNase T1 protection analysis. Twenty micrograms of total RNA was used for this analysis. tRNA: lanes 1, 6, 14. Lanes 1–5,
Mtv-2-specific probe; lanes 6– 10, Mtv-9/17-specific probe; lanes 11–13, Mtv-7-specific probe; lanes 14–18, Mtv-1/3-specific probe. ex, exogenous
MMTV(C3H) virus.
1, -6, -8, -11, and -14) and the lymphoid tissue of AKR/ containing viral particles in GR milk (not shown). In con-
trast to GR animals, no Mtv-17 was detected in the milkNCr (Mtv-7, -8, -9, -17, -23, and -30) mice. With the Mtv-
2-specific probe, the 280-nt protected fragment was seen produced by B10.BR females (Fig. 3, lane 3); this provirus
must be defective and can be produced as viral particleswith RNA isolated from GR lactating and virgin mammary
gland (Fig. 2, lane 5 and 4). With the Mtv-7-specific probe, only in the presence of the packaging proteins provided
by Mtv-2 in the GR mice. Thus, RNA transcribed fromthe 220 nt, fully protected fragment was detected only
with RNA isolated from GR (Fig. 2, lane 12) and AKR/NCr Mtv-3 and Mtv-17 were potential partners for recombina-
tion with Mtv-2.(Fig. 2, lane 13) spleens but not GR (Fig. 2, lane 11)
or AKR/NCr (not shown; Ross and Golovkina, in press)
DNA isolated from GR mammary gland tumors andmammary glands. Therefore, the Mtv-7 locus was only
normal mammary gland tissues contain newlyexpressed in the lymphoid organs of GR mice and thus,
acquired recombinant MMTV provirusescannot participate in recombination with Mtv-2 in the
mammary gland. With the Mtv-1/3-specific probe, the All mammary gland tumors induced by MMTV contain
343-nt fragment corresponding to full-length protection newly acquired copies of integrated proviruses (Cohen
of the probe was seen with RNA isolated from both GR and Varmus, 1980). The majority of these tumors are
mammary gland and spleen, corresponding to Mtv-3 (Fig. clonal and have MMTV proviruses integrated near cellu-
2, lanes 17, 18, and 16, respectively). With the Mtv-9/17-
specific probe, the 340-nt fragment resulting from expres-
sion of Mtv-17 was seen in the mammary glands of GR
(Fig. 2, lanes 9 and 10) and B10.BR (Fig. 2, lanes 7) mice.
We previously have shown that Mtv-9 is expressed only
in lymphoid cells (Ross and Golovkina, in press).
These experiments showed that in addition to Mtv-2,
Mtv-3 and -17 are expressed in the GR mammary gland.
Viral particles from GR milk contained Mtv-3 and Mtv-
17 RNAs
FIG. 3. Copackaging of Mtv-2 and Mtv-17 in the milk of GR mice.Since Mtv-3 and Mtv-17 were expressed in the GR
RNA was isolated from high-speed pellets of GR, C3H/HeN MMTV/mammary gland, they could be copackaged with Mtv-2.
and B10.BR milk as described (Golovkina et al., 1994) and subjectedTherefore, RNase T1 protection assays were performed to RNase T1 protection assay with the Mtv-2 and Mtv-9/17 probes.with RNA isolated from the virus fraction of GR milk (Fig. Lanes 1–7, Mtv-9/17-specific probe; lanes 8–13, Mtv-2-specific probe.
3). RNA isolated from the milk of B10.BR females served Lanes 1 and 8, tRNA; lanes 2 and 9, RNA isolated from GR milk; lanes
3 and 10, B10.BR milk; lanes 4 and 11, C3H/HeN MMTV/ milk; lanesas a control for virus packaging of the Mtv-17 RNA in the
5 and 12, GR lactating mammary gland; lanes 6 and 13, B10.BR lactatingabsence of infectious endogenous or exogenous
mammary gland; lane 7, C3H/HeN MMTV0 lactating mammary gland.MMTVs.
Lower molecular weight fragments partially protected by the probes
Virions isolated from GR milk contained a large amount correspond to RNA produced by Mtv-1 and MMTV(C3H) in C3H/HeN
of Mtv-17, as well as Mtv-2 RNA (Fig. 3, lanes 2 and MMTV/ milk (lanes 4) and to RNA produced by Mtv-1 in C3H/HeN
MMTV0 mice (lane 7). ex, exogenous MMTV(C3H) virus.9, respectively). We also detected production of Mtv-3-
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(except for 45489 and 44659) showed increased hybrid-
ization to the 2.1-kb fragment, corresponding to the pol-
env part of either Mtv-3, -7, -8, or -17. Interestingly, two
tumors (44377 and 44379; lanes 18 and 20, Fig. 5) con-
tained many additional copies of such newly acquired
endogenous MMTVs. Therefore, the newly acquired pro-
viruses found in the mammary tumors and nonmalignant
mammary tissues of GR mice contained additional cop-
ies of both Mtv-2 and another endogenous MMTV(s). An
increase in the number of the newly acquired endoge-
nous MMTV proviruses could be seen in the nonmalig-
nant tissues as well as in the mammary gland tumors
(Table 1 and Fig. 5, compare lanes 2–5 with lane 1).FIG. 4. Map of the endogenous proviruses present in the GR genome.
However, the nonmalignant mammary gland tissue con-After BglII and PstI digestion, Mtv-2 generates 2.3- and 1.5-kb frag-
ments, whereas the 2.1- and 3.0-kb fragments are derived from Mtv- sists of both infected and uninfected cells, unlike the
3, -7, -8, -17. Probe 1, XhoI– XhoI fragment isolated from the plasmid tumors which are clonal, so this represents the average
HYB PRO as previously described (Golovkina et al., 1994); probe 2, copy number of newly integrated MMTVs.PstI –PstI fragment containing env, isolated from the plasmid p1.1 (Ma-
We first examined whether additional copies of Mtv-3jors and Varmus, 1983). The location of the primers used for RT-PCR
were present in the tumors, since this locus has a com-are shown as arrows above the map of Mtv-2. P, PstI; B, BglII; E, EcoRI;
C, ClaI; U, PvuII; M, MunI. U shown in the open box, the unique Mtv- plete proviral stucture and is expressed in the mammary
17 PvuII site, there are additional PvuII sites (not shown); E shown in gland of GR. Mtv-3 is the only provirus in GR mice that
the box, the unique Mtv-3 EcoRI site. Only the relevant sites are shown. has two EcoRI sites (Fig. 4). Digestion of Mtv-3-containing
DNA with EcoRI and ClaI and hybridization to probe 2
yields fragment of 1.1 kb specific for this provirus (Kozaklar oncogenes (Peters and Dickson, 1987). Restriction
enzyme mapping of the newly integrated proviruses et al., 1987). The DNAs of several tumors were digested
with EcoRI and hybridized to probe 2 (Fig.4); no amplifica-found in GR mammary gland tumors showed that they
contained additional copies of Mtv-2 (Cohen and Varmus, tion of this endogenous locus was detected in any of the
tumors analyzed (data not shown).1980). Since we found that there was copackaging of
two additional endogenous MMTV proviruses with Mtv-
2, it was possible that some of the mammary tumors Recombinant viruses found in GR tumors contain the
contained newly acquired copies of recombinant provi- Mtv-17 env gene and 3*LTR
ruses, similar to what was seen in MMTV(C3H)-induced
mammary gland tumors (Golovkina et al., 1994). Since none of the tumors analyzed showed increased
hybridization to the 3.0-kb gag-pol fragment of the nonin-To determine whether there were recombinant provi-
ruses, DNA was extracted from 12 independent mam- fectious MMTVs (Mtv-3, -7, -8, -17) (Fig. 5), the newly
acquired proviruses most likely were recombinant, withmary gland tumors as well as the nonmalignant mam-
mary tissues from virgin GR females and subjected to gag-pol derived from Mtv-2 and env derived from another
MMTV, most likely Mtv-17. To determine whether Mtv-17Southern blot analysis. The tumor DNAs were digested
with PstI and BglII and hybridized to probe 1 (Fig. 4). This contributed to the recombinant viruses found in the GR
mammary gland tumors and tissues, we took advantageanalysis allowed us to distinguish Mtv-2 from Mtv-3, -7,
-8, and -17 because of an additional PstI site in the gag of restriction fragment length polymorphisms found in
MMTV proviruses. Mtv-17 contains a unique PvuII site ingene of the former and a BglII site in the env gene of
the latter 4 proviruses (Fig. 4). The Mtv-2 locus yielded its env gene 1 kb upstream of a ClaI site (Fig. 4) (Peterson
et al., 1985). Therefore, digestion of Mtv-17-containingfragments of 1.5 kb (gag-pol) and 2.3 kb (pol-env),
whereas digestion of the other proviruses yielded frag- DNA with ClaI and PvuII and hybridization to probe 2
(diagrammed in Fig.4) yields a 1-kb fragment. DNA fromments of 3.0 kb (gag-pol) and 2.1 kb (pol-env) (Fig. 4).
Amplification of the hybridization signal to the 2.3- or 1.5- several tumors was digested with ClaI and PvuII and
hybridized to probe 2. All the tumor DNAs analyzed dem-kb fragments would show the acquisition of additional
copies of Mtv-2 in the tumors, whereas increased hybrid- onstrated increased hybridization to the 1-kb fragment
(Fig. 6, compare lanes 1, 2, 3 with lane 6, and compareization to the 3.0- or 2.1-kb fragments would indicate
that there were additional copies of endogenous MMTVs lane 4 to lane 6). From these analyses, we concluded
that a recombinant virus containing part of the Mtv-17other than Mtv-2.
According to this analysis, all the tumor DNAs as well env gene was amplified in most of GR tumors. The 1.5-
and 2.5-kb fragments are the result of partial digestionas DNA isolated from the nonmalignant mammary tissue
contained amplified copies of the Mtv-2 provirus (Fig. 5 with ClaI (data not shown); the same fragments are pres-
ent in the splenic DNA (Fig. 6, lanes 6–8).and Table 1). In addition, most of the samples analyzed
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FIG. 5. Restriction fragment length analysis of the newly acquired MMTV proviruses found in the GR mammary gland tissues and tumors. High-
molecular-weight DNAs from nonmalignant mammary gland tissues (lanes 2–8, 16, 19, 21), mammary gland tumors (lanes 9–15, 17, 18, 20, 22)
and from the spleen (lane 1) were digested with BglII and PstI and subjected to Southern blot analysis with probe 1 (Fig. 4). Twenty micrograms
of DNA was used for this analysis. Mouse 45489, mammary gland tissue (MG) and mammary gland tumor (MGT), lanes 8 and 15, respectively;
mouse 44658, MG and MGT, lanes 7 and 14; mouse 45499, MG and MGT, lanes 6 and 13; mouse 45498, MG and MGT, lanes 5 and 12; mouse
44660, MG and MGT, 4 and 11; mouse 45500, MG and MGT, lanes 3 and 10; mouse 44659, MG and MGT, lane 2 and 9; mouse 44376, MG and
MGT, lanes 16 and 17; mouse 44515, MG and MGT, lanes 21 and 22; mouse 44379, MG and MGT, lanes 19 and 20; mouse 44377, MGT, lane 18.
These results showed that the recombinant viruses reverse primer specific for the Mtv-2 sag should be di-
gested by both PvuII and MunI, generating fragments offound in mammary gland tumors of GR mice contained
the 5* LTR, gag and pol genes from Mtv-2 and the env 2.5, 0.4, and 0.1 kb.
When this analysis was carried out with RNA isolatedgene from Mtv-17. To determine the origin of the sag in
these proviruses, we isolated RNA from tumor 44379, from the lactating mammary gland of B10.BR (Mtv-17) a
decrease in the molecular weight of the RT-PCR productwhich contained a large number of recombinant viruses
(Fig. 5, lane 20) and subjected this RNA to RT-PCR analy- was seen upon digestion with PvuII but not MunI (Fig.
7B), corresponding to expression of Mtv-17. With RNAsis. Primers specific for the Mtv-2 or Mtv-17 sag were
used in combination with a primer that hybridized to the isolated from the lactating mammary gland of GR (Mtv-
2, Mtv-17) mice, the Mtv-17-specific RT-PCR product wasenv of all MMTVs. After RT-PCR, the amplified products
were digested with PvuII or MunI; PvuII cuts uniquely in
the env of Mtv-17 and MunI cuts at nt 521 of only the
Mtv-2 LTR alone (Fig. 4). Therefore, if the recombinant
viruses contained the sag of Mtv-2 and the env gene of
Mtv-17, some of the RT-PCR products produced with the
TABLE 1
Recombinant MMTV Can Be Detected in Normal GR Mammary
Gland Tissues and Tumors
Additional copies
no. of other
Additional copies endogeneous
no. of Mtv-2 a MMTVsa
Mouse MG MGT MG MGT
45500 4 4 5 5
44660 4 19 6 6
45498 5 10 7 7
45499 5 7 9 9
44658 3 6 1 4
45489 43 66 0 1
44659 3 77 0 0
44381 14 18 12 12 FIG. 6. Recombinant proviruses found in mammary tumors contain
the Mtv-17 env gene. Five micrograms of high-molecular-weight DNA44376 2 20 3 4
44379 5 8 198 492 isolated from mammary gland tissue (MG) (lanes 2 and 5) and mam-
mary gland tumors (MGT) (lanes 1, 3, and 4) as well as the spleen44515 5 44 7 13
44377 ND 5 ND 572 (lanes 6–8) were digested with PvuII and ClaI and hybridized to probe
2 (Fig. 4). MG and MGT (lanes 2 and 3, respectively) of mouse 44379;
MGT (lane 1) of mouse 44377; MGT and MG (lanes 4 and 5, respec-a See Materials and Methods for calculations used to determine the
copy number. MG, mammary gland; MGT, mammary gland tumor; ND, tively) of mouse 44515. Lane 6, 7, 8 represent 5, 10, and 20 mg of the
GR splenic DNA, respectively.not determined.
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locus from GR mice resulted in a congenic line GR.Mtv-
20, in which no mammary gland tumors developed (van
Nie and de Moes, 1977). In another mouse strain, WXG-
2, which bears Mtv-2 as its only endogenous MMTV pro-
virus, mammary tumors were observed (Morris et al.,
1986). However, in contrast to the 97% mammary tumor
incidence seen in GR mice, only 25% of WXG-2 mice
developed mammary gland tumors (Morris et al., 1986).
This suggests that there is more than one factor involved
in MMTV-induced mammary gland tumorigenesis in GR
mice.
Our experiments suggest that Mtv-17 contributed to
the high percentage of mammary gland tumors that occur
in GR mice. Mtv-17 is expressed in the mammary gland
of GR animals and efficiently packaged in the presence
of Mtv-2. Previously, Kuo et al. showed that the 3* LTR
of Mtv-17 could not direct glucocorticoid-inducible tran-
scription of a linked gene in transfection studies (Kuo et
al., 1988). The authors attributed this to a Mtv-17-specific
G-to-A transition detected in the NF-1 transcription factor
binding site found in the MMTV promoter. Either this
mutation does not affect transcription in vivo or the 3*
LTR used to direct expression in the transfection experi-
ments had a mutation not found in the 5* LTR of this
FIG. 7. Recombinant virus has 3* LTR of Mtv-17 endogenous provirus.
provirus. We have found Mtv-17 transcripts in the mam-(A) RT-PCR assays using primers specific for env and Mtv-2 sag region
mary glands of a number of inbred mouse strains, includ-followed by PvuII, MunI digestion were performed with RNA isolated
from B10.BR or GR lactating mammary gland and tumor as described ing C57BL/6 (Ross and Golovkina, in press), the strain
under Materials and Methods. T2, RNA isolated from tumor 44379. RT, from which the 3* LTR of Mtv-17 used in the studies{ reverse transcriptase. (B) RT-PCR using primer specific for env and described above was cloned (Peterson et al., 1985), indi-
Mtv-17 sag followed by PvuII, MunI digestion were performed with the
cating that the transcription is not strain-specific.same RNAs. The 1-kb ladder (GIBCO/BRL) was used as a molecular
In addition to Mtv-17, Mtv-3 is also expressed andweight marker (MW).
efficiently packaged in the mammary glands of GR mice.
However, we detected no additional copies of Mtv-3-
digested with PvuII, but not with MunI (Fig. 7B) and the containing proviruses in the mammary gland tumors, in-
Mtv-2-specific product was digested with MunI but not dicating that Mtv-17 is contributing a specific function to
PvuII (Fig. 7A). When RNA isolated from tumor 44379 the process of infection or tumorigenesis. The region of
was subjected to the similar analysis, all the Mtv-2 sag Mtv-17 found in the recombinant virus contained the env
specific RT-PCR products were digested only with MunI gene. This finding suggests that there is a requirement
but not with PvuII (Fig. 7A) and all Mtv-17-specific prod- for a functional Mtv-17 env coding region. It has been
ucts were digested with PvuII but not MunI (Fig. 7B). The reported that Mtv-3 doesn’t produce any Env proteins
same experiments were done with a number of tumor (Nusse et al., 1980), which may explain why it doesn’t
RNAs as well as DNAs and similar results were obtained contribute to the recombinant viruses.
(data not shown). These data suggested that all the re- The majority of mammary gland tumors contained
combinant viruses expressed in the GR mammary gland newly acquired viruses with the Mtv-17 env. Proviruses
tumor contained the Mtv-17 sag. with the same structure were also found in nonmalignant
mammary gland tissues. In contrast to the tumors, the
mammary gland tissue consists of a polyclonal cell popu-DISCUSSION
lation, and therefore, contains cells each with a different
number of acquired proviruses. Although, Mtv-17 is ex-Genetic studies have revealed that the inbred mouse
strain GR contains a dominant gene for the induction of pressed at much lower levels than Mtv-2 in the GR mam-
mary gland (Fig. 2, compare lanes 4 and 9), we weremammary gland tumors and that this gene is the Mtv-2
endogenous provirus. This was shown in several ways. able to detect newly acquired viruses with the Mtv-17
env gene in this polyclonal population. This indicatesFirst, DNA isolated from GR mammary gland tumors con-
tained newly acquired proviral copies that had character- that recombinant MMTVs with the Mtv-17 env gene were
selected at a step prior to tumorigenesis.istic restriction enzymes sites specific for Mtv-2 (Cohen
and Varmus, 1980). Second, the removal of the Mtv-2 What role might the Mtv-17 Env protein play in the
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virus’ ability to cause tumors? A major determinant of situ infection of the mammary gland, it is not known if
there is a requirement for a specific Sag. That the recom-host susceptibility or resistance to retroviral infection is
the interaction between the virion glycoproteins and their binant viruses retained the Mtv-17 sag indicates that Sag
is not involved in situ MMTV-induced tumorigenesis orcellular receptors. Resistance to viral infection can occur
because of the absence of receptors or the saturation of infection. Alternatively, if Sag is required for infection or
tumorigenesis in GR mice, there could be selection forreceptors with Env glycoproteins already present in cells
expressing other exogenous or endogenous viruses with the Mtv-17 sag in the recombinant viruses. Interestingly,
it was recently reported that the Mtv-17 locus causesthe same specificity (receptor interference) (Weiss, 1984).
For example, both murine (Stoye et al., 1991) and feline very poor deletion of Sag-cognate T cells (Scherer et al.,
1995). Thus, mice containing Mtv-17 still retain T cells(Overbaugh et al., 1988) leukemia viruses have been
shown to aqcuire part of the env gene of their respective capable of interacting with its Sag. It is not known what
effect the Mtv-2 Sag has on the T-cell immune repertoireendogenous counterparts during the process of tumori-
genesis. The generation of recombinant Env proteins of GR mice, but since it is expressed in the lymphoid
tissues of these animals, in contrast to Mtv-17 (Golovkinaboth allows these viruses to overcome receptor interfer-
ence and to play a role in tumorigenesis. Receptor inter- and Ross, in press), it likely causes complete deletion
of Sag-reactive T cells. Therefore, if in situ infection orference for MMTV has not been well studied due to the
difficulty in establishing productive infection in vitro. tumorigenesis requires the stimulation of T cells, the re-
combinant viruses with Mtv-17 sag may be selected be-However, it has been reported that the Env glycoprotein
of Mtv-1 and MMTV(C3H) recognize different receptors cause of the persistence of its Sag-reactive T cells.
(Altrock et al., 1981) and we found previously that many
of the tumors induced by MMTV(C3H) had a recombinant ACKNOWLEDGMENTS
virus containing the env gene of Mtv-1 (Golovkina et al.,
We acknowledge the members of our laboratory for helpful discus-1994). Therefore, one possibility is that the Mtv-2 and
sions and Dr. J. Dudley for critical review of the manuscript. We thankMtv-17 Env proteins recognize different receptors. This
Roy Coleman and Marta de Olano Vela for technical assistance. Wewould imply that Mtv-2, which is highly expressed in the
thank Dr. B. Huber for the plasmid containing the LTR of Mtv-7 and Dr.
GR mammary gland, has to change its receptor specific- D. O. Peterson for the plasmid TR1.10. T. V. Golovkina was a Cancer
ity to reinfect efficiently. This would explain the lower Research Institute fellow. This work was supported by Public Health
Services Grant CA45954 from the National Cancer Institute.tumor incidence in the WXG-2 mice, since Mtv-2 alone
may not efficiently infect mammary gland cells.
The results presented here suggest that the Mtv-17 REFERENCES
Env provides a new specificity for Mtv-2. This hypothesis
Acha-Orbea, H., Shakhov, A. N., Scarpellino, L., Kolb, E., Muller, V.,also suggests that there is no saturation of the Mtv-17-
Vessaz-Shaw, A., Fuchs, R., Blochlinger, K., Rollini, P., Billotte, J.,specific receptor in normal mammary gland epithelial
Sarafidou, M., MacDonald, H. R., and Diggelman, H. (1991). Clonal
cells. This could be due to the lower level of transcription deletion of Vb14-bearing T cells in mice transgenic for mammary
of this provirus relative to Mtv-2. Alternatively, the viruses tumor virus. Nature 350, 207–210.
Altrock, B. W., Arthur, L. O., Massey, R. J., and Schochetman, G. (1981).we detected in the mammary gland tumors and nonma-
Common surface receptors on both mouse and rat cells distinguishlignant tissues may have recombinant Mtv-2/Mtv-17 Env
different classes of mouse mammary tumor virus. Virology 109, 257–proteins with a new receptor specificity. The identifica-
266.
tion of the recombination breakpoints in such tumors will Bentvelzen, P. (1968). Resistance to small amounts of Bittner mammary
allow us to determine whether such hybrid env genes tumor virus in offspring of C57BL female with the virus. J. Natl. Cancer
Inst. 41, 757–765.have been created.
Bentvelzen, P., and Daams, J. H. (1969). Hereditary infections with MTVThe acquired viruses with Mtv-17 env were recombi-
in mice. J. Natl. Cancer Inst. 43, 1025–1035.nant, since their gag-pol region was derived from Mtv-2.
Bentvelzen, P. (1972). Host-virus interactions in murine mammary carci-
We have not precisely defined the breakpoints of the nogenesis. Biochim. Biophys. Acta 355, 236–259.
recombination for these viruses. However, it appears that Beutner, U., Frankel, W. N., Cote, M. S., Coffin, J. M., and Huber, B. T.
(1992). Mls-1 is encoded by the long terminal repeat open readingall the viruses derived their sag from the Mtv-17 virus.
frame of the mouse mammary tumor provirus Mtv-7. Proc. Natl. Acad.This is in contrast to the recombinant viruses found in
Sci. USA 89, 5432–5436.C3H/HeN MMTV/ mice, where env came from the en-
Brandt-Carlson, C., Butel, J. S., and Wheeler, D. (1993). Phylogenetic
dogenous noninfectious Mtv-1 locus and sag from the and structural analysis of MMTV LTR ORF sequences of exogenous
exogenous virus (Golovkina et al., 1994). In this case, and endogenous origins. Virology 185, 171–185.
Choi, Y., Kappler, J. W., and Marrack, P. (1991). A superantigen encodedhowever, only the milk-borne viruses encoding exoge-
in the open reading frame of the 3* long terminal repeat of the mousenous Vb14-stimulating Sag proteins would be capable
mammary tumor virus. Nature 350, 203–207.of infecting mice, since Mtv-1-cognate Vb3-bearing T
Choi, Y., Marrack, P., and Kappler, J. W. (1992). Structural analysis of
cells are deleted from the immune repertoire of C3H/ a mouse mammary tumor virus superantigen. J. Exp. Med. 175, 847–
HeN (Pullen et al., 1992). In the case of an endogenous, 862.
Coffin, J. M. (1990). Retroviridae and their replication. In ‘‘Virology’’infectious provirus such as Mtv-2, where there can be in
AID VY 7821 / 6a13$$$301 03-01-96 07:03:16 vira AP: Virology
22 GOLOVKINA, PRAKASH, AND ROSS
(B. N. Fields and D. M. Knipe, Eds.) pp. 1437–1500. Raven Press, DNA in inbred, wild and Asian mice, and in tumors and normal
organs from inbred mice. J. Mol. Biol. 114, 73–91.New York, NY.
Muhlbock, O. (1965). Note on a new inbred mouse strain GR/A. Eur. J.Cohen, J. C., Shank, P. R., Morris, V. L., Cardiff, R., and Varmus, H. E.
Cancer 1, 123–124.(1979). Integration of the DNA of mouse mammary tumor virus in
Muhlbock, O., and Bentvelzen, P. (1968). The transmittion of the mousevirus-infected normal and neoplastic tissue of the mouse. Cell 16,
mammary tumor virus in mice. Perspect. Virol. 6, 75.333–345.
Nusse, R., de Moes, J., Hilkens, J., and van Nie, R. (1980). LocalizationCohen, J., and Varmus, H. (1980). Proviruses of mouse mammary tumor
of a gene for expression of mouse mammary tumor virus antigens
virus in normal and neoplastic tissues from GR and C3Hf mouse
in the GR.Mtv-20 mouse strain. J. Exp. Med. 152, 712–719.
strains. J. Virol. 35, 298–305.
Overbuagh, J., Riedel, N., Hoover, E. A., and Mullins, J. I. (1988). Trans-
Golovkina, T. V., Chervonsky, A. V., Dudley, J. P., and Ross, S. R. (1992). duction of endogenous envelope genes by feline leukemia virus in
Transgenic mouse mammary tumor virus superantigen expression vitro. Nature 332, 731–733.
prevents viral infection. Cell 69, 637–645. Peters, G., and Dickson, C. (1987). On the mechanism of carcinogenesis
Golovkina, T. V., Jaffe, A. B., and Ross, S. R. (1994). Coexpression of by mouse mammary tumor virus. In ‘‘Cellular and Molecular Biology
exogenous and endogenous mouse mammary tumor virus RNA in of Breast Cancer’’ (D. Medina, W. Kidwell, G. Heppner, and E. Ander-
vivo results in viral recombination and broadens the virus host range. son, Eds.), pp. 307–319. Plenum, New York, NY.
Peterson, D. O., Kriz, K. G., Marich, J. E., and Toohey, M. G. (1985).J. Virol. 68, 5019–5026.
Sequence organization and molecular cloning of mouse mammaryGolovkina, T. V., Dudley, J. P., Jaffe, A. B., and Ross, S. R. (1995). Mouse
tumor virus DNA endogenous to C57BL/6 mice. J. Virol. 54, 525–531.mammary tumor viruses with functional superantigen genes are se-
Pullen, A. M., Choi, Y., Kushnir, E., Kappler, J., and Marrack, P. (1992).lected during infection in vivo. Proc. Natl. Acad. Sci. USA 92, 4828–
The open reading frames of several mouse mammary tumor virus4832.
integrants encode Vb3-specific superantigens. J. Exp. Med. 175, 41–Kozak, C., Peters, G., Pauley, R., Morris, V., Michalides, R., Dudley. J.,
47.Green, M., Davisson, M., Prakash, O., Vaidya, A., Hilgers, J., Vers-
Ross, S. R., and Golovkina, T. V. The role of endogenous MMTV loci
traeten, A., Hynes, N., Diggelman, H., Peterson, D., Cohen, J. C.,
in resistance to MMTV-induced mammary tumors. In ‘‘Viral Superanti-
Dickson, C., Sarkar, N., Nusse, R., Varmus, H., and Callahan, R.
gens’’ (K. Tomonari, Ed.), CRC press, FL, in press.
(1987). A standardized nomenclature for endogenous mouse mam- Scherer, M. T., L. Ignatowicz, A. Pullen, J. Kappler, and Marrack, P.
mary tumor viruses. J. Virol. 61, 1651–1654. (1995). The use of mammary tumor virus (Mtv)-negative and single-
Kuo, W.-L., Vilander, L. R., Huang, M., and Peterson, D. O. (1988). A Mtv mice to evaluate the effects of endogenous viral superantigens
transcriptionally defective long terminal repeat within an endogenous on the T cell repertoire. J. Exp. Med. 182, 1493–1504.
copy of mouse mammary tumor virus proviral DNA. J. Virol. 62, 2394– Stoye, J. P., Moroni, C., and Coffin, J. M. (1991). Virological events
2402. leading to spontaneous AKR thymomas. J. Virol. 65, 1273–1285.
van Nie, R., and de Moes, J. (1977). Development of a congenic line ofMajors, J., and Varmus, H. (1983). Nucleotide sequencing of an apparent
the GR mouse strain without early mammary tumors. Int. J. Cancer.proviral copy of env mRNA defines determinants of expression of
20, 588.the mouse mammary tumor virus env gene. J. Virol. 47, 495–504.
van Nie, R., Verstaeten, A. A., and de Moes, J. (1977). Genetic transmis-Michalides, R., and Schlom, J. (1975). Relationship in nucleic sequences
sion of mammary tumor virus by GR mice. Int. J. Cancer 19, 383–between mouse mammary tumor virus variants. Proc. Natl. Acad.
390.Sci. USA 72, 4635–4639.
Varmus, H., Bishop, J. M., Nowinski, R., and Sarkar, N. (1972). Mammary
Moore, D. H., Long, C. A., Vaidya, A. B., Sheffield, J. B., Dion, A. S., and
tumor virus specific nucleotide sequences in DNA of high and low
Lasfargues, E. Y. (1979). Mammary tumor viruses. Adv. Cancer Res.
incidence mouse strains. Nature 238, 189–190.
29, 347–418. Weiss, R. (1984). Experimental biology and assay of RNA tumor viruses.
Morris, D. W., Young, L. J. T., Gardner, M. B., and Cardiff, R. D. (1986). In ‘‘RNA Tumor Viruses: Molecular Biology of Tumor Viruses’’ (R.
Transfer, by selective breeding, of the pathogenic Mtv-2 endogenous Weiss, N. Teich, H. Varmus, and J. Coffin, Eds.), pp. 209–260. Cold
provirus from the GR strain to a wild mouse line free of endogenous Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
and exogenous mouse mammary tumor virus. J. Virol. 58, 247–252. Yang, J., and Dudley, J. (1992). Endogenous Mtv-8 or a closely linked
Morris, V. L., Medeiros, E., Ringold, G. M., Bishop, J. M., and Varmus, sequence stimulates rearrangement of the downstream Vk9 gene.
J. Immunol. 149, 1242–1251.H. E. (1977). Comparison of mouse mammary tumor virus-specific
AID VY 7821 / 6a13$$$301 03-01-96 07:03:16 vira AP: Virology
